中文
About Us
Corporate Overview
Management Team
Board of Directors
Contact Us
Our Science
Anti-viral Platform
RNA Interference
Fatty Liver Disease
Products & Pipline
Overview
HCV
HBV
ASC09
ASC06
Partnership
Investors
Financials & Filing
Presentation Materials
News
2020
2019
2018
2017
2016
2015
2014
Careers
2020
2019
2018
2017
2016
2015
2014
Medivir Licenses Exclusive Rights to MIV-802 for Greater China to Ascletis
2017-08-18
